cSDHaSDHsubdural haematoma (SDH)MEDLINEPubMedPROSPEROPROSPEROCochrane LibraryEpileptic seizures (ES)
…me (RR=1.38, 95% CI 1.10 to 1.73; p<0.001; I ²=83%), whereas in cSDH, only a non-significant trend was observed (RR=1.79, 95% CI 0.7…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 194 of 2459Parkinson’s DiseasePDSTN-DBSParkinson’s Disease-Motorsymmetric PDsubthalamic deep brain stimulation
…’s Disease-Motor ADL scale. Secondary outcomes included Unified Parkinson’s Disease Rating Scale motor examination and Parkinson’s Disease Question…
anifrolumabSLEERYTHRONCT06046534NCT04750057
…e experience of patients with moderate-to-severe SLE initiating anifrolumab treatment through routine clinical practice as part of two earl…
CRCB. catenulatumimmunotherapycolorectal cancerazoxymethane/dextran sulfate sodium
…through enhancing intratumoural CD8+ T cell infiltration in MSS CRC models of Apcmin/+ mice and CT26 allografts. B. catenulatum-der…
98.7%
Sirolimuscardiac rhabdomyomaRapamunecardiac rhabdomyomastuberous sclerosisEuropean Medicines AgencyPfizer Limitedrespiratory support
…een administered. The 2nd level was reported at 52.4nanogram/ml.Sirolimus levels continued to be monitored; 18 days after the last dose t…
sodium valproatevalproatevalproate-reproductive-risksMedicines and Pregnancy RegistryteratogenicityMedicines and Healthcare products Regulatory AgencyMHRA
…afety Alert (NatPSA) introduced updated regulatory measures for sodium valproate prescribing due to its teratogenicity. 1 Despite stringent meas…
vancomycincytarabineCentral Line-associated Bloodstream InfectionsCLABSI
…comitantly taking the nephrotoxic drug, cytarabine and thus the vancomycin was discontinued.Conclusion This study highlights that continuo…
ST-segment elevation myocardial infarctionfibrinolysisSTEMIdelayed primary PCItimely primary PCI
…und Time to reperfusion is a predictor of long-term outcomes in ST-segment elevation myocardial infarction (STEMI). Timely primary percutaneous coronary intervention (PCI…
Bipolar disorderquetiapinebipolar depressionlamotriginearipiprazolesertralineolanzapineNIHR132773fluoxetineMedicines and Healthcare products Regulatory Agency+1 more
…Introduction Bipolar disorder affects around 2% of the population and is linked with reduced …
melanomapembrolizumabdabrafenibsponsorstrametinibtertiary hospital
…13,812.28 per patient.Conclusion and Relevance Participation in melanoma clinical trials generates substantial economic savings by reduc…
myelomabrexucabtagene autoleucelbrexi-celtisagenlecleucelaxicabtagene ciloleuceltertiary oncology centretisa-celaxi-celchemo refractory aggressive B-cell lymphomas
…n patients with chemo refractory aggressive B-cell lymphomas or myeloma. Emerging evidence suggests that delayed CAR T-cell infusion, i…
amphotericin Bfluconazolevaginal candidiasisVaginal fungal infectionsCandida kruseiamoxicillin-clavulanatemiconazoleOrionClinic
…as Candida krusei. The successful treatment with the compounded amphotericin B preparation underscores the importance of microbiological cultu…